Evidence map›Paper›PMID 30369904›Full record

ArticleFrontiers in neurology2018

The Role of Prescribing Generic (Non-proprietary) Drugs in the Prevalence of Therapeutic Inertia in Multiple Sclerosis Care.

Gustavo Saposnik, Muhammad Mamdani, Maria Terzaghi, Maria Laura Saladino, Berenice Silva, Philippe N Tobler, Fernando Caceres

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Tough versus soft regulations to promote generic medications in Italy.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  3. Article
  4. Article
  5. Multiple sclerosis in Colombia: A review of the literature.Multiple sclerosis journal - experimental, translational and clinical
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Gustavo SaposnikDivision of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto Toronto, ON, Canada.
Muhammad MamdaniLi Ka Shing Centre for Healthcare Analytics Research and Training (LKS-CHART) Toronto, ON, Canada.
Maria TerzaghiDecision Neuroscience Unit, St. Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto Toronto, ON, Canada.
Maria Laura SaladinoDepartment of Neurology, Institute of Neuroscience Buenos Aires (INEBA) Buenos Aires, Argentina.
Berenice SilvaDepartment of Neurology, Institute of Neuroscience Buenos Aires (INEBA) Buenos Aires, Argentina.
Philippe N ToblerLaboratory for Social and Neural Systems Research, Department of Economics, University of Zurich Zurich, Switzerland.
Fernando CaceresDepartment of Neurology, Institute of Neuroscience Buenos Aires (INEBA) Buenos Aires, Argentina.
Instituto de Neurología de Buenos Aires · ARLaboratory for Social and Neural Systems Research · CHSt. Michael's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

decision makingdisease-modifying therapygeneric drugsinertiamultiple sclerosisoutcomesrisk aversion

Identifiers

PMID30369904
PMCPMC6194175
OpenAlexW2905479930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.